Ingrid Abrahamsen

Executive Director, Head of Clinical Operations

Fulcrum Therapeutics

Brian Alexander, MD, MPH

CEO

Valo Health

Kevin Anderson

Sr. Director, Clinical Operations, Therapeutics

Moderna

Christopher Arendt

Chief Science Officer, Head of Research

Takeda

Mark Arquiza

Associate Director, Clinical Monitoring Oversight

Apellis Pharmaceuticals

Ashley Avery

Senior Specialist, Quality Documents & Archival

AbbVie

Carla Bauer

Director, Oncology Search and Evaluation, Business Development & Licensing

Merck

Daniel Beal

Director, Clinical Program Lead

Mediar Therapeutics

Eric Blanchard

Partner

Cooley LLP

Irene Blat

Head of External Innovation, North America

Servier

Paul Bolno

President & CEO

Wave Life Sciences

Ben Bradford

Head of External Affairs

MassBio

Carolyn Britten, MD

VP, Clinical Development, Solid Tumors,

BeOne

Jared Brooslin

Senior Manager, Trial Master File

Intellia Therapeutics

Karim Budhwani

CEO-Scientist

CerFlux

Stephen Bychowski

General Counsel, Assistant General Counsel BD&L Pharma

Sanofi Ventures

Scott Cenci

SVP, Chief Information & Data Officer

Acadia Pharmaceuticals

Moitreyee Chatterjee-Kishore

Head of Oncology Development

Astellas Pharma Inc.

Priya Chaturvedi

VP,  Head of Global Clinical Quality

Eisai

Kleem Chaudhary

Chief Executive Officer

Hyku Biosciences

Ron Cooper

CEO

enGene

Helena Cowley

Director, Global Alliance Management

Takeda

Ann DeWitt

Siegrid Delgadillo

Director, eTMF services

Premier Research

Manisha Desai

Senior Vice President, Product Development, Product Development & Supply

Bristol Myers Squibb

Scott Dewire

Corporate Senior Vice President & Head of Global Business Development

Boehringer Ingelheim

Elena Diez Cecilia, PhD, MBA

Senior Director, External Innovation, DPDS

Janssen R&D

Susan Edelstein

SVP, Clinical Research

Ardelyx

Debbie Etchison

Executive Director, Head of Corporate Affairs

Alkeus Pharmaceuticals

Stephanie Fagan

Chief Corporate Affairs Officer

Definium Therapeutics

Liz Farrell

Director, Compliance and TMF Oversight

Agios Pharmaceuticals

Adam Feire

Head of Business Development and External Innovation

Biogen

Rosalie Filling

Vice President & Senior Global Head of R&D Strategy, Innovation & Operations

Keenova Therapeutics

Susan Fitzpatrick-Napier

CEO

TrialWire

Tori Fort

SVP, Corporate Strategy and Corporate Affairs

Ovid Therapeutics

Kristen Fortney, PhD

Co-Founder & CEO

BioAge Labs

Diana Gallagher, MD

SVP, Head of Clinical Development for MS, Immunology and Alzheimer

Biogen

Sarah Ganley

Associate Director of Standards & Processes

Arrowhead Pharmaceuticals

Harry Georgiades

Managing Director

IPM

Nicole Glazer

Senior Vice President, R&D Data, Digital, and Technology

Takeda

Kelly Gold

CFO

CAMP4 Therapeutics

Rob Goldstein-Mahon

Executive Director, Patient Advocacy

Ionis Pharmaceuticals

Colleen Graham

SVP, Clinical Operations

Mediar Therapeutics

Abigail Gregor

Partner, Life Sciences Licensing & Collaborations

Ropes & Gray

Joseph Grieco

VP of Clinical Development

Tris Pharma

John Gustofson

Head

Chugai Venture Fund

Sue Hager

Advisory Partner

Andreessen Horowitz

Rebecca Halbur

Associate Director, TMF Records Mangement, Cinical Trial Systems & Operations

Moderna

Catherine Hall

Head of GXP Quality Assurance

Egnyte

Alison Handley

VP and Head, Center for External Innovation

Takeda

Nick Hardaden

Sr. Director, TMF

Merus N.V.

Jamie Harrop

Vice President Clinical Operations

Beam Therapeutics

Sheela Hegde

Managing Partner & Global Head

Health Advances

Echo Hindle-Yang

Founder and Chief Executive Officer

MSQ Ventures

Mary Jane Hinrichs

Senior Vice President, Early Development,

Ipsen

Narimon Honarpour, MD, PhD

Senior Vice President, Global Development

Amgen

Christelle Huguet

Executive Vice President, Head of R&D

Ipsen

Youssef Idelcaid

Head of AI Research Center

Gilead Sciences

Darren Incorvaia

Staff Writer

Fierce Biotech

Allison Intondi

VP, Clinical Operations

Coherus Biosciences

Christiana Iyasere

MD, MBA, Senior Director Technology Business Development and Accelerator

Dana-Farber Cancer Institute

Anthony Jarkowski

Senior Vice President, Primary Focus Lead, Head of Immuno-Oncology

Astellas Pharma

Padmini Jayaraman

Jose Juves

Chief Corporate & Patient Affairs Officer

Dyne Therapeutics

Fraiser Kansteiner

Associate Editor

Fierce Pharma

Ariel Katz

CEO and Co-founder

H1

Abbas Kazimi

Chief Executive Officer

Nimbus Therapeutics

Adam Keeney

Executive Vice President and Head of Corporate Development

Biogen

Jared Kelly

CEO

Oncolytics Biotech

Ryan Kelly

Chief Communications Officer

Recursion

Matthew Kennedy

AVP, Neuroscience and Neuroimmunology Lead

Merck

Prarthana Khanna PhD

Vice President, Corporate Business Development and Strategy

Vico Therapeutics

Peter Kilford, PhD

Associate Vice President, Software Business Development

Simulations Plus

Jessica Kirshner

Vice President of Oncology and Immuno-Oncology

Regeneron

Andrew Lam

Managing Director, Head of Biotech Private Equity

Ally Bridge Group

Rita Lemming

Director, Clinical Operations

Fulcrum Therapeutics

Lizabeth Leveille

Vice President, BD&L and Head, Boston Innovation Hub & Discovery Transactions

Merck

Michael Levey

Director, Global Media Relations

Merck

Stacy Lindborg, PhD

President, Chief Executive Officer & Board Director

IMUNON, Inc.

Alex Loboda

Director, Clinical Quality

Korro Bio

Hobson Lopes

Associate Director, Records and Archive Management

Regeneron

Karla MacDonald

Chief Corporate Affairs Officer

Entrada Therapeutics

Maria Maccecchini

CEO

Annovis

John Maraganore, PhD

Founding and Co-CEO,

Corsera Health, Alnylam Pharmaceuticals; CEO and Principal, JMM Innovations

Jennifer McCafferty, PhD,

Senior Vice President, Head of CMC-Regulatory and MRL Quality Assurance,

Merck

Theresa McNeely

Chief Communications Officer

Lifordi Immunotherapeutics, Inc.

Rachel Mercado

Principal, AI consulting

IQVIA

Liza Micioni

Sr. Director, Head of Clinical Operations

Tris Pharma, Inc.

Brian Miglionico

Vice President, Business Developmeny

Agios Pharmaceuticals

Emilijia Mitrikeska

Associate Director, Business Development

University of Michigan Medical School | Rogel Cancer Center

Amber Monaghan

Director

IPM

Ahmed Mousa

Chief Executive Officer

Vicore Pharma

Curran Murphy

Senior Director Clinical Operations / Head of Clinical Business Operations

Blueprint Medicines

John Murray

VP Global Business Development & Country Head UK

SanaClis

Nikhil Mutyal

Head of Search and Evaluation - Respiratory & Immunology

AstraZeneca

Miki Nakamori

Executive Director, Head of Scouting & Transaction, PFGR/BR, Business Development

Astellas Pharma Inc.

Tatiana Novobrantseva, PhD

Chief Scientific Officer

NextPoint Therapeutics

Kate O'Malley

Vice President, Corporate Affairs

Moderna

Emily Oldshue

Partner

Ropes & Gray

Jacob Petersen

Senior Vice President, Diabetes, Obesity and MASH Therapeutic Area

Novo Nordisk

Raviv Pryluk

CEO & Co Founder

PhaseV

Maha Radhakrishnan

Executive Partner, Private Equity

Sofinnova Investments

Bhaskar Rege, PhD

Senior Vice President, Pharmaceutical and Early-Stage Development

Alkermes

Kevin Richards

Sr. Director, Clinical Quality

AstraZeneca

Kristen Riemenschneider

Partner

Freshfields

Kendra Rose

Senior Vice President, Head of BD&L/OI New Platforms Cardiovascular & Immunology

Bayer

Mark Rutter

VP, Regulatory Affairs

Formation Bio

Dennis Salotti

Sr. Director & Head, Strategic Outsourcing & Clinical Innovation

Jazz Pharmaceuticals

Amber Salzman, Ph.D.

CEO

Epicrispr Biotechnologies

Frédéric Scaerou

Head of Global Business Development

Servier

Marc Schwabish

Chief Business Officer

Tectonic Therapeutic

Evan Seigerman

Evan Seigerman, Managing Director, Head of Healthcare Research BioPharma & Biotechnology

BMO Capital Markets

Madeleine Shin

Executive Director, Global Head of External Communications and Media

Biogen

David Soergel, MD

Chief Medical Officer

Madrigal

Morten Sogaard

SVP, Head of Innovation Lab

Astellas

Erik Sokolowski

Zevra Therapeutics

Tracy Sorrentino

Vice President, Corporate Affairs

Sarepta Therapeutics

Rob Staszewski

Associate Director, Clinical Oversight & Systems

United Therapeutics

Mary Kathryn Steel

Executive Director of Leadership and Enterprise Communications

Bristol Myers Squibb

Sriram Subramania

CEO & Founder

Ferma

Joseph Szustakowski

Vice President of Clinical Development Data Science and AI

Genmab

Charles Theuer M.D. Ph.D.

Chief Medical Officer

Halozyme

Claris Tsang Munksgaard

Director, Global Business Development and Licensing

EMD Serono, Inc

Peter Tummino

President of Research & Development

Nimbus Therapeutics

Steph Viscomi

Director, TMF Management

Apellis Pharmaceuticals

James Waldron

UK/EU Bureau Chief

Fierce Biotech

John Wichelt

VP of Operations and Site Director

Kindeva Bridgeton

Jane Williams

Vice President, Medical Management

Syneos Health

Juliet Williams, PhD

Head of Research

Kymera

Vanessa Wolfeler

CEO

SERB Pharma